Tuberculosis: 12. Global disease and the role of international collaboration

CMAJ. Canadian Medical Association Journal

Volumn 162, Issue 1, 2000, Pages 57-61

  Enarson, Donald A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULOSTATIC AGENT;

BCG VACCINATION; DISEASE TRANSMISSION; DRUG COST; GOVERNMENT; HUMAN; INTERNATIONAL COOPERATION; MYCOBACTERIUM TUBERCULOSIS; REVIEW; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL; VOLUNTEER; WORLD HEALTH ORGANIZATION;

EID: 0034635119     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. 1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality. Bull World Health Organ 1994;72:213-30.
2. 2. Long R, Njoo H, Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ 1999;160:1185-90.
3. 3. FitzGerald JM, Houston S. Tuberculosis: 8. The disease in association with HIV infection. CMAJ 1999;161:47-51.
4. 4. Calmette A, Negre L, Boquet A. Essai de vaccination du lapin et du cobaye contre l'infection tuberculeuse. Ann Inst Pasteur 1922;36:625-35.
5. 5. Fox W, Mitchison DA. Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1975;111:325-53.
6. 6. Fine P. BCG vaccination against tuberculosis and leprosy. Br Med Bull 1988;44:691-703.
7. 7. Comstock GW. The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research. Clin Infect Dis 1994;19:528-40.
8. 8. Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle 1976;57:17-43.
9. 9. D'Arcy Hart P, Sutherland I. Final report of the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ 1977;2:293-5.
10. 10. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976;57:275-99.
11. 11. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954;69:724-32.
12. 12. Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 1975;50:90-106.
13. 13. World Health Organization. WHO Expert Committee on Tuberculosis, Ninth Report. Tech Rep Ser 552. Geneva: The Organization; 1974.
14. 14. Krivinka R, Drapela J, Kubik A, Dankova D, Krivanek J, Ruzha J, et al. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia. Bull World Health Organ 1974;51:59-69.
15. 15. Andersen S, Bannerji D. A sociological inquiry into an urban tuberculosis control programme in India. Bull World Health Organ 1963;29:685-700.
16. 16. Waaler II, Geser A, Andersen S. The use of mathematical models in the study of the epidemiology of tuberculosis. Am J Public Health 1962;6:1002-13.
17. 17. Mahler H. "Posthumous" letter to Dr. Holm [memorial]. Bull Int Union Tuberc 1990;65(4):82.
18. 18. Kleeberg HH, Olivier MS. A world atlas of initial drug resistance. 2nd ed. Pretoria: Tuberculosis Research Institute, South African Medical Research Council; 1984.
19. 19. Grzybowski S, Enarson DA. The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc 1978;53:70-5.
20. 20. Crofton J. The contribution of treatment to the prevention of tuberculosis. Bull Int Union Tuberc 1962:32:643-53.
21. 21. Frimodt-Moller J. Changes in tuberculosis prevalence in a south Indian rural community following a tuberculosis control programme over a seven years' period. Ind J Tuberc 1962:9:187-91.
22. 22. Zhang LX, Kan GQ. Tuberculosis control programme in Beijing. Tuber Lung Dis 1992;73:162-6.
23. 23. Enarson DA. Principles of IUATLD collaborative national tuberculosis programmes. Bull Int Union Tuberc Lung Dis 1991;66:195-200.
24. 24. World Bank. World development report 1993: investing in health. Oxford: Oxford University Press; 1993.
25. 25. Hershfield E. Tuberculosis: 9. Treatment. CMAJ 1999;161:405-11.
26. 26. Enarson DA, Grosset J, Mwinga A, Hershfield ES, O'Brien R, Cole S, et al. The challenge of tuberculosis: statements on global control and prevention. Lancet 1995;346:809-10.
27. 27. Enarson DA. Why not the elimination of tuberculosis? [editorial]. Mayo Clin Proc 1994;69:85-6.
28. 28. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996;347;358-62.
29. 29. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144:741-2.